5 IP Legal Mistakes Small Companies Make When Working with Large Companies

March 8, 2011

Open Innovation Legal Insights

Jackie Hutter is my favorite IP attorney in open innovation.  She has done a lot of interesting deals and represented both large and small companies.  Below is a great article by her – Ben

Small companies CAN effectively partner with large companies in Open Innovation…

Open Innovation guru Stefan Lindegaard recently asked me what the biggest IP legal mistakes small companies make when they are working with large companies. This is a subject very near and dear to my heart, as I am currently “moonlighting” as GC of a start up energy company that is moving toward licensing our technology into large companies. Also, as a senior IP lawyer at a multi-national consumer products company, I was on the other side of such deals on more occasions than I can count. Prior to that, I was a law firm partner representing large and small corporations in patents and licensing issues, and in doing so, I now realize that I killed more deals than I ever facilitated, a situation that is more typical of law firm lawyers than it should be, unfortunately.

In view of this multi-faceted experience, I present this list of the 5 most common mistakes companies make when working with large companies in Open Innovation.

1. Thinking you have all the answers for the large company’s problems:

As a small company, you often have only have a single idea or technology and you quite properly focus your attention in this direction. This can be damaging to your ability to do complete an Open Innovation deal with a big company, however. The large company may not care about what you see as the value of your technology because they are the experts in their products and customers. Indeed, you may be wholly wrong about why the large company is interested in speaking to you. If you want to sell or license your technology to a large company, your best bet is to focus on the specific technology aspects, and leave the business and customer issues to the other side, at least at the early stages of discussion.

2. Bringing the wrong lawyer to the table:

Very often small companies assume the lawyer who handles their intellectual property issues is the appropriate person to bring to a conversation with the big company. However, the legal skills a small company needs to obtain its patent rights are very different than what are needed to get a deal done. While protection of your small company’s IP should be paramount in any dealings with the large company, putting up complicated restrictions about the use and ownership of your IP even before you know a deal is likely to happen, which is the natural inclination of most IP attorneys, can often end up in the other party walking away before a deal is even underway. I have found the best lawyers to negotiate deals in the Open Innovation context are business-focused attorneys, who tend to be people who have served a stint in the corporate world and who might even have little experience with high-end IP issues. It can be tough to find someone with these credentials, however. As an alternative, I like to work with licensing experts, most of whom have successfully closed most deals in a year than many law firm IP lawyers see in their entire careers. These licensing experts are frequently not lawyers, but they have negotiated enough agreements to be very good at spotting the legal issues and, in this regard, they often do a better job than lawyers.

3. Putting the legal issues ahead of the business issues:

Read the rest of this entry »


Innovation Outside of the Box

March 3, 2011

Innovation is all about taking the common and regular, and changing it for the better. Here is a quick video about the reinvention of the shoe box by Puma.  At yet2ventures, we are fascinated by breakthrough consumer packaging.


Users Guide to Silicon Valley

February 23, 2011

Starting in the fall last year I began spending at least a week a month in the Valley. I came across this great article by Steve Blank which describes a bunch of things to do in the Valley…. it almost a beginner guide to Silicon Valley. I highly recommend the read – Ben

If you’re a visiting dignitary whose country has a Gross National Product equal to or greater than the State of California, your visit to Silicon Valley consists of a lunch/dinner with some combination of the founders of Google, Facebook, Apple and Twitter and several brand name venture capitalists. If you have time, the President of Stanford will throw in a tour, and then you can drive by Intel or some Clean Tech firm for a photo op standing in front of an impressive looking piece of equipment.

The “official dignitary” tour of Silicon Valley is like taking the jungle cruise at Disneyland and saying you’ve been to Africa. Because you and your entourage don’t know the difference between large innovative companies who once were startups (Google, Facebook, et al) and a real startup, you never really get to see what makes the valley tick.

If you didn’t come in your own 747, here’s a guide to what to see in the valley (which for the sake of this post, extends from Santa Clara to San Francisco.) This post offers things to see/do for two types of visitors: I’m just visiting and want a “tourist experience” (i.e. a drive by the Facebook / Google / Zynga / Apple building) or “I want to work in the valley” visitor who wants to understand what’s going on inside those buildings.

I’m leaving out all the traditional stops that you can get from the guidebooks.

Hackers’ Guide to Silicon Valley
Silicon Valley is more of a state of mind than a physical location. It has no large monuments, magnificent buildings or ancient heritage. There are no tours of companies or venture capital firms. From Santa Clara to South San Francisco it’s 45 miles of one bedroom community after another. Yet what’s been occurring for the last 50 years within this tight cluster of suburban towns is nothing short of an “entrepreneurial explosion” on par with classic Athens, renaissance Florence or 1920’s Paris. Read the rest of this entry »


2011 Patent Buying Areas of Interest report

February 16, 2011

We’ve been buying and selling patents at yet2.com for over 11 years now. Over those years we have seen the areas of patent interest change quite substantially.  Today we released our 2011 Patent Buying Areas of Interest report. This years’ report breaks patents sales into four areas; Consumer Electronics, Wireless, Healthcare and Lighting.  Contact us for the full report, but below is a summary.

Most patent transactions are in industries where there are a high number of patents per product.  Consumer electronics leads the pack.  We are seeing an increase in interest in patents around the edges of consumer electronics, like hardware casing and metal bending. The patent market is coming back to a ‘new normal’, after the 2008 market disruption.  While transaction activity has picked back up, it’s still at 50% of pre 2008.

Patent Buying Interest Areas (2011)

1. Consumer Electronics

a) Image Capture / Image processing

b) Audio/Video

c) Memory

d) Compression / Decompression (“codec”)

e) Displays

f) Battery / Portable Power

g) Sensors Read the rest of this entry »


yet2.com Open Innovation Conference, Boston, May 17th to 19th

February 10, 2011

yet2.com hosts a fantastic Open Innovation conference annually.  Typically more than 50 of the Fortune 500 participate.  It’s a very active hands on event.  Key speakers are from; P&G, DSM, DuPont, Tyco, Colgate- Ben

PS  Previously, our speakers have included; Dean Kamen, Dr. Oz, Henry Chesbrough, Esther Dyson, etc.

The event is an intimate technology scouting and networking conference for executive Open Innovation, technology, R&D, licensing, and business leaders. Recent conferences have averaged 120–140 leaders representing 100+ global corporations from six continents. Big enough to be global, small enough to encourage meaningful conversation.

This year the event will be held May 17-19th at the Hyatt Regency Cambridge, MASS USA.

Speakers include:

Dr. Kenneth W. Klimpel, Worldwide Director – External Innovation, Colgate Palmolive, Stephen J. Baggott, Director, Global Business Development, Procter & Gamble, Jim Toth, PhD, Sr. Director of Technology Strategy, Tyco Electronics, Marcel Lubben, Managing Director, DSM Venturing and DSM Licensing, and Michael T. Kane, Founder, Fairbridge Venture Partners.

Past attendees include: Agfa, Amway, Ashland, AT&T, Bayer, BP, Catepillar, Ciba, DSM, DuPont, Eastman Chemical, GE, Georgia-Pacific, W.L. Gore, Honeywell, IBM, Microsoft, NASA, Northrop Grumman, P&G, Royal Dutch Shell, Samsung, SAP, Tyco,Unilever, Wrigley.

A complete list of speakers and past attendees can be found here.


The next killer app – How Open Innovation Will Change Drug Developement

January 29, 2011

This is an interesting article available here in Sunday’s Boston Globe. I wrote a very similar article on how digital exhaust will cure cancer. I think people will have the ability to opt out/in of large scale medical studies on each of our collective digital exhaust to better understand the cause and effect of various ailments. Add to this, transparency in the food supply (so that we will know what came from where), and we will have some very interesting data on which to develop new therapies. This is a fascinating topic – Ben

Online communal wisdom should be harnessed for drug development

NEW DRUGS are subject to exhaustive critical scrutiny, yet there has never been a corresponding effort to collect reports of drugs delivering unexpected benefits. If open innovation can lead to the creation of the world’s most complete encyclopedia, a top-selling cleaning duster, and the game Angry Birds, it’s time to ask whether this approach might be used to capture the exceptional untapped value associated with existing drugs, and to power the discovery of important new medicines.

Half a century ago, astute clinicians noticed that patients receiving the new anti-tuberculosis drug iproniazid experienced an enhanced sense of well-being, a chance observation that led directly to the development of antidepressants and the birth of psychopharmacology. More recently, an unexpected side effect reported by patients in a clinical trial of a drug for chest pain led to the development of Viagra.


Deloro Signs LOI For The Acquisition Of New Heavy Oil Property at the Wilkie Project

January 26, 2011

Electro Petroleum is a yet2Ventures portfolio company, and it’s the key partner to Deloro – Ben

January 25, 2011 Deloro Resources Ltd. (TSX.V – DLL) is pleased to announce that the Company has entered into a Letter of Intent for the acquisition of a new heavy oil property adjoining the Wilkie project in Saskatchewan.

The proposed new acquisition includes 320 acres containing the rights to petroleum from surface to the top of the Precambrian, 120 acres containing the rights to petroleum and natural gas from the base of the Mannville to the top of the Precambrian and 840 acres containing the rights to petroleum and natural gas from surface to the top of the Precambrian. This property will be acquired from Canadian Natural Resources for the sum of $15,000.00 and the assumption of all environmental and reclamation obligations.
Read the rest of this entry »


yet2.com forms yet2Ventures investment fund and teams up with Japan’s JAIC

January 24, 2011

Tokyo, Japan and Boston, MA USA, 24 January 2011 — yet2.com has formed yet2Ventures, a fund created to help Fortune 500 firms and other owners of venture capital investments drive value in their portfolio companies. We can provide follow-on investment and liquidity to help small companies grow. We are excited about this effort and believe yet2.com is uniquely positioned to help portfolio companies grow with:

  • Our global network, with offices in Tokyo, Boston, Liverpool, and Wilmington
  • Our IP experience
  • Our technology licensing experience
  • And, now our capital

Venture funding is an excellent fit with the established yet2.com market, where we help large and small companies connect on new and robust technologies.

Our first joint investment with JAIC is in Avantis Medical Systems of Sunnyvale, California. They develop and manufacture catheter-based endoscopic devices for detecting and treating cancer in the GI tract.

The yet2Ventures fund is a good partnership opportunity for VC firms and other strategic investors. Perhaps we can help your portfolio grow, too? Please contact us at:venturefund@yet2.com.

About JAIC

Japan Asia Investment Co., Ltd. (JAIC) is an independent venture capital company founded in 1981 by the Japan Association of Corporate Executives (Keizai Doyukai). JAIC’s operations are centered on three geographic hubs — Japan, Asia, and the United States. In these regions, JAIC provides financial support for companies in various stages of development from promising venture enterprises to companies with succession or business reorganization needs, or firms looking to revitalize their businesses. In addition, JAIC seeks to stimulate growth and raise the corporate value of invested companies by providing support on the management side as well. These include supplying information, consulting for initial public offerings (IPO), and business matching.

About yet2.com

yet2.com provides intellectual property consulting and licensing services to world-class clients around the globe. Yet2.com Inc and its online marketplace were founded in 1999 to promote Open Innovation, with original investments from Siemens, Bayer, Honeywell, DuPont, Procter & Gamble, Caterpillar, and NTT Leasing. The privately held company has offices in the United States, Europe, and Japan. The web site now has over 120,000 registered marketplace users including many of the Fortune 500 and over 16,000 smaller technology companies. In addition to its core team, yet2.com has created a wide network of Open Innovation partners covering many of the technology-rich countries around the world as well as relationships with open innovation organizations, technical expert networks, SME networks, technical magazines, online technical communities, and technology brokers. These provide market-wide access to technologies and needs in countries such as Russia, China, India, Korea, Brazil, South Africa, Japan, the US, and the EU. For more information, visit www.yet2.com or contact Tim Bernstein 1-781-972-0600.

 


TED Talk by Carlos Oliveira Santos – About Open Innovation

January 18, 2011

This is a very clever talk by Carlos Oliveira Santos from TEDxEdges 2010.


yet2.com Webinar – Successfully marketing your technologies to non-traditional customers

January 7, 2011

Please join us for our next FREE webinar — 20 January 2011 at 11:00 am – 12:30 pm EST US. (8:00 am PST. 17:00 UK.)

Register here: https://www2.gotomeeting.com/register/437414154

Most companies know their regular customers very well. But how can you best market your technologies to non-traditional customers? In yet2.com’s next FREE webinar, three highly experienced marketers share their views on capitalizing on the growing desire for externally developed technology by chemical, materials, and consumer products companies.

Speakers include:

  • Ben du Pont, President, yet2.com and yet2Ventures

Follow

Get every new post delivered to your Inbox.